CEO / Board paid big money to manage Mayne and thus far performance wise is abysmal we're looking at another calendar year coming up still sitting at record lows . Present management were gifted millions of dollars to kick start this stock thanks to MCS and generic's being sold off virtually making Matne debt free , somehow management have managed to drop our shares below what they were when they first took over . We're worse off far worse off now than we were before , at least we had something to sell then now we have nothing to sell if / when we need working capital ( capital raising ? further devaluing our shares , ) running at a loss for how long and how much longer nobody knows two years according to some analysts + management has yet to know the ( findings) in regards our involvement in regards collusion between generic drug companies if Trump gets elected and pushes the DOJ to hand out harsh penalties to named companies involved in price fixing .
MYX Price at posting:
$4.50 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)